www.fdanews.com/articles/71960-barr-third-quarter-misses-estimates-shares-fall
Barr Third-Quarter Misses Estimates, Shares Fall
May 5, 2005
Barr Pharmaceuticals said its fiscal third-quarter profit rose, but revenue fell and results missed analyst estimates, sending shares down 6 percent. Barr's third-quarter net income rose to $61.3 million, or 58 cents per share, compared with $35.1 million, or 33 cents per share a year earlier. While branded product sales rose 83 percent and margins rose to 70 percent from 54 percent, total revenue fell to $265 million from $321 million.